Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guidalberto Manfioletti

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Endocrinology|July 24, 2018
Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin FactorEusebio Chiefari, Daniela P Foti, Riccardo Sgarra, et al.
Development Genes and Evolution|May 6, 2017
The HMGA gene family in chordates: evolutionary perspectives from amphioxusMatteo Bozzo, Simone Macrì, Daniela Calzia, et al.
BMC Cancer|July 21, 2006
HEX expression and localization in normal mammary gland and breast carcinomaCinzia Puppin, Fabio Puglisi, Lucia Pellizzari, et al.
Oncotarget|August 16, 2013
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemnessSilvia Pegoraro, Gloria Ros, Silvano Piazza, et al.
Cancers|August 7, 2019
HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer CellsCarlotta Penzo, Laura Arnoldo, Silvia Pegoraro, et al.
Biochemistry|April 16, 2003
Molecular dissection of the architectural transcription factor HMGA2Barbara Noro, Barbara Licheri, Riccardo Sgarra, et al.
Cancer Research|March 17, 2006
HMGA1 inhibits the function of p53 family members in thyroid cancer cellsFrancesco Frasca, Alessandra Rustighi, Roberta Malaguarnera, et al.
Cancer Research|July 5, 2002
Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene functionDeborah S Hunter, Michael Klotzbücher, Hiroyuki Kugoh, et al.
Cell Death & Disease|February 9, 2018
The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffoldSonia Ciotti, Riccardo Sgarra, Andrea Sgorbissa, et al.
Theranostics|November 24, 2021
Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal modelsLila Rouland, Eric Duplan, Lígia Ramos Dos Santos, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Endocrinology|July 24, 2018
Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin FactorEusebio Chiefari, Daniela P Foti, Riccardo Sgarra, et al.
Development Genes and Evolution|May 6, 2017
The HMGA gene family in chordates: evolutionary perspectives from amphioxusMatteo Bozzo, Simone Macrì, Daniela Calzia, et al.
BMC Cancer|July 21, 2006
HEX expression and localization in normal mammary gland and breast carcinomaCinzia Puppin, Fabio Puglisi, Lucia Pellizzari, et al.
Oncotarget|August 16, 2013
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemnessSilvia Pegoraro, Gloria Ros, Silvano Piazza, et al.
Cancers|August 7, 2019
HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer CellsCarlotta Penzo, Laura Arnoldo, Silvia Pegoraro, et al.
Biochemistry|April 16, 2003
Molecular dissection of the architectural transcription factor HMGA2Barbara Noro, Barbara Licheri, Riccardo Sgarra, et al.
Cancer Research|March 17, 2006
HMGA1 inhibits the function of p53 family members in thyroid cancer cellsFrancesco Frasca, Alessandra Rustighi, Roberta Malaguarnera, et al.
Cancer Research|July 5, 2002
Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene functionDeborah S Hunter, Michael Klotzbücher, Hiroyuki Kugoh, et al.
Cell Death & Disease|February 9, 2018
The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffoldSonia Ciotti, Riccardo Sgarra, Andrea Sgorbissa, et al.
Theranostics|November 24, 2021
Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal modelsLila Rouland, Eric Duplan, Lígia Ramos Dos Santos, et al.
Pageof 7